ViewRay Stock (NASDAQ:VRAY)
Previous Close
$0.03
52W Range
$0.02 - $0.04
50D Avg
-
200D Avg
-
Market Cap
-
Avg Vol (3M)
$13.06M
Beta
0.70
Div Yield
-
VRAY Company Profile
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.
VRAY Performance
Peer Comparison
| Ticker | Company |
|---|---|
| ATEC | Alphatec Holdings, Inc. |
| ANIK | Anika Therapeutics, Inc. |
| OFIX | Orthofix Medical Inc. |
| AVNS | Avanos Medical, Inc. |
| SGHT | Sight Sciences, Inc. |
| DCTH | Delcath Systems, Inc. |
| TIVC | Tivic Health Systems, Inc. |
| NPCE | NeuroPace, Inc. |
| AORT | Artivion, Inc. |
| AXGN | AxoGen, Inc. |
| BBLG | Bone Biologics Corporation |
| HSCS | Heart Test Laboratories, Inc. |
| ESTA | Establishment Labs Holdings Inc. |
| INGN | Inogen, Inc. |
| CVRX | CVRx, Inc. |
| VVOS | Vivos Therapeutics, Inc. |